Digital Pathology Market Anticipated to Grow Exponentially by 2031

The Global Digital Pathology Market Size By Product(Scanners, Software, Communication Systems, and Storage Systems), By Application(Disease Diagnosis, Teleconsultation, Drug Discovery), By End-User(Pharmaceutical & Biotechnology Companies, Hospitals, and Reference Laboratories), and Forecast published by Verified Market Research.

Digital Pathology Market Gains Traction with Consistent Growth Trajectory, Expected to Surge in the Forecasted Period of 2024-2031

>>> Download PDF Brochure:

Browse in-depth TOC on “Global Digital Pathology Market”

54 – Tables

26 – Figures

85 – Pages

>>> View Detailed Table of Content Here:

Global Digital Pathology market size and forecast

Digital pathology is a subspecialty of pathology that focuses on data management using data acquired from digitized specimen slides. With the use of computer-based technologies, digital pathology performs virtual microscopy. Despite the fact that the basic viewing capabilities have remained relatively the same, digital pathology has resulted in considerable advances in pathology lab efficiency, workflow, and revenue. The increased implementation of this pathology to improve lab efficiency is propelling the global market forward. The rising frequency of cancer is expected to boost demand for digital pathology, and the market will grow at a rapid rate as a result. According to the WHO study, cancer is responsible for around 1 in every 6 deaths globally. Lung, prostate, colorectal, stomach, and liver cancer are the most common cancers in males, whereas breast, colorectal, lung, cervical, and thyroid cancer are the most common cancers in women. Cancer is becoming more common across the world, putting great physical, emotional, and financial strain on people, families, governments, and health systems. Digital pathology has a lot of potential in terms of treating a variety of ailments. The rising frequency of cancer illness has necessitated intensive diagnostic and clinical research, of which it is an important component. Furthermore, increased investment in emerging economies in the healthcare sector, as well as expanding use in drug development and companion diagnostics, are helping the growth of the market. However, various constraints are limiting the worldwide digital pathology market’s growth. The high cost of these systems might stifle the global digital pathology market’s expansion. Furthermore, the scarcity of skilled personnel would provide several obstacles to the market’s growth throughout the projection period. Nonetheless, the development of low-cost scanners is projected to provide profitable growth prospects for market participants.

Global Digital Pathology market segmentation

On the basis of geographical segments, the Digital Pathology market is dominated by the North American area. Early acceptance of Digital Pathology and the introduction of multiple providers offering Digital Pathology are projected to drive market growth in the area. The growing prevalence of cancer and the rising need for high-quality diagnostics are driving the growth of the North American Market. The market is divided into Scanners, Software, Communication Systems, and Storage Systems based on product. Due to the growing usage of solutions throughout the world, the scanners segment led the worldwide digital pathology market. Furthermore, the rising incidence and prevalence of cancer and other chronic illnesses are predicted to propel the digital pathology industry forward. The market is divided into four categories based on application: Disease Diagnosis, Teleconsultation, Drug Discovery, and Training & Education. Because of the growing demand for numerous preclinical and clinical studies performed during the drug discovery and development process, the drug discovery segment dominated the global digital pathology market.

Key Players

The major players in the global digital pathology market are 3DHISTECH, Hamamatsu Photonics, Leica Biosystems, Koninklijke Philips, Apollo Enterprise Imaging, XIFIN, Ventana Medical Systems, Visiopharm, Corista, and Huron Digital Pathology.

About Verified Market Research

Advanced analytical research solutions within one platform- Verified Market Research. Offering information enriched research studies that include primary and secondary research studies. Verified Market Research assists in understanding holistic industrial factors and trends.

Analysts with high expertise in data gathering and governance utilize industry techniques to collate and examine data at all stages. Our analysts are trained to combine modern data collection techniques, superior research methodology, subject expertise, and years of collective experience to produce informative and accurate research reports.

Verified market research partners with clients to provide insight into strategic and growth analytics; data that help achieve business goals and targets. Our core values include trust, integrity, and authenticity for our clients.

Our research studies help our clients to make superior data-driven decisions, capitalize on future opportunities, optimize efficiency, and keep them competitive by working as their partners to deliver the right information without compromise.

Contact details:

US Toll Free No: +1 (800) 782 1768

Direct US No: +1 (650) 781 4080


Visit Our Website:

Download Sample Report